Sign in

CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
412193603
Phone
650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
  1. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $0.64 ($3,200)
  2. 4 Open-market sale Chief Financial Officer sold 155 shares at $0.77 ($119)
  3. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $0.73 ($3,650)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 7,260 shares at $1.05 ($7,598)
  6. 4 Grant or award Director acquired 2,174 shares (grant or award)
  7. 4 Grant or award Director acquired 2,174 shares (grant or award)
  8. 4 Grant or award Director acquired 2,174 shares (grant or award)
  9. 4 Grant or award Director acquired 2,174 shares (grant or award)
  10. 4 Grant or award Director acquired 2,174 shares (grant or award)
  11. 4 Grant or award Director acquired 2,174 shares (grant or award)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at an average $0.99 ($9,856)
  13. 4 Derivatives Options or other derivatives
  14. 4 Option exercise 10% owner acquired 755,000 shares (option exercise)
  15. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 9,000 shares (grant or award)
  16. 4 Shares withheld for taxes Chief Engineering Officer gave up 406 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 450 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 558 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 1,623 shares (to pay taxes)
  20. 4 Grant or award Chief Medical Officer acquired 18,000 shares (grant or award)

Page 3 of 21 · 404 filings